• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALCON RESEARCH, LLC - HUNTINGTON CLAREON ASPHERIC HYDROPHOBIC ACRYLIC IOL; INTRAOCULAR LENS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALCON RESEARCH, LLC - HUNTINGTON CLAREON ASPHERIC HYDROPHOBIC ACRYLIC IOL; INTRAOCULAR LENS Back to Search Results
Model Number SY60WF
Medical Device Problem Code Product Quality Problem (1506)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 08/20/2025
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
The lens was returned positioned incorrectly in the lens case inside the lens carton.Viscoelastic was dried on the lens.One haptic was bent in the gusset areas with the distal area folded across the optic edge, similar to have been loaded into a cartridge.The lens was cleaned with klrp to further evaluate.The bent haptic relaxed into the original position after the removal of the dried viscoelastic.The other haptic was scraped across the anterior gusset area.A dimensional inspection was conducted.The lens dimensions (plan view) met specifications per an approved template.A device history record review and a non-conformance review of the reported lot number was conducted.The deviation review did not reveal any potential contributing factors to the reported complaint and all corresponding production release specifications defined in the device master record were met.Associated product information was not provided.It is unknown if qualified products were used.The root cause is most likely related to user handling.One haptic was bent and folded onto the optic edge, similar to have been loaded into a cartridge.The other haptic was scraped.Viscoelastic was dried on the lens.This was most likely interpreted as the reported complaint of "looked defective".All lenses are 100% inspected for cosmetic attributes and the damage exhibited by the returned complaint sample would not have met company's release criteria.Based on our observation, it can be reasonably concluded that the damage is not manufacturing related.Due to the presence of surgical solution and the condition of the returned sample, the damage is most likely related to customer handling.The lens was cleaned to remove the viscoelastic.The bent haptic relaxed into the original position.A dimensional inspection was conducted.The lens dimensions (plan view) met specifications per an approved template.It is unknown if qualified associated products were used.The instructions for use (ifu) instructs: company foldable intraocular lens (iols) are qualified for use with a company qualified delivery system (handpiece and cartridge) and ophthalmic viscosurgical device (ovd) combination.The ifu instructs that a company qualified delivery system and viscoelastic combination should be used.The use of an unqualified combination may cause damage to the lens and potential complications during the implantation process.The ifu instructs: using holding forceps, grasp the lens by the optic edge and gently place the lens anterior side up into the back of the ovd-filled cartridge.The lens should be inserted until the optic is a little more than half-way inside the cartridge.Use the holding forceps to gently push down on the lens, verifying that the lens is on the bottom surface of the cartridge.Using holding forceps, take the trailing haptic, and gently fold the haptic onto the anterior side of the optic.Slowly grip or push the optic edge to position the lens as far into the cartridge as the forceps will permit, while ensuring the lens remains on the bottom surface of the cartridge and the trailing haptic remains on the optic.Failure to follow these steps may cause the lens to advance incorrectly causing delivery issues and/or damage.The ifu instructs: follow the section regarding directions for use for information on the maximum allowed time for the iol to stay in the folded condition.Failure to adhere to manufacturer¿s recommendations may result in iol damage.Ifu note: during lens loading and insertion, do not allow the company iol to remain in a folded condition within the selected iol delivery system for more than 3 minutes prior to completing insertion into the capsular bag.The manufacturer internal reference number is: (b)(4).
 
Event or Problem Description
A non-healthcare professional reported that during the intraocular lens (iol) implant procedure iol found to be defective.Additional information had been received and stated that, the physician was not comfortable implanting it because it looked defective.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CLAREON ASPHERIC HYDROPHOBIC ACRYLIC IOL
Common Device Name
INTRAOCULAR LENS
Manufacturer (Section D)
ALCON RESEARCH, LLC - HUNTINGTON
246 kyle lane
huntington WV 25702
Manufacturer (Section G)
ALCON RESEARCH, LLC - HUNTINGTON
246 kyle lane
huntington WV 25702
Manufacturer Contact
jonathan schlech
6201 south freeway
mail stop ab2-6
fort worth, TX 76134
8007579780
MDR Report Key23035795
Report Number1119421-2025-02458
Device Sequence Number9329421
Product Code HQL
UDI-Device Identifier00380652251501
UDI-Public(01)00380652251501(17)290326(11)250328(10)16012654
Combination Product (Y/N)N
Initial Reporter StateNY
Initial Reporter CountryUS
PMA/510(K) Number
P190018
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Initial Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date (Section B) 09/12/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model NumberSY60WF
Device Catalogue NumberSY60WF.210
Device Lot Number16012654
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer09/09/2025
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 08/19/2025
Initial Report FDA Received Date09/12/2025
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured03/28/2025
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-